Company news
Replimune Group, Inc. news in 2019
Replimune Group, Inc.'s news releases, calls and decks from 2019, newest first.
Replimune Strengthens Executive Team with the Appointment of Jean Franchi as Chief Financial Officer
December 8, 2019
Replimune to Present at the Piper Jaffray 31st Annual Healthcare Conference
November 25, 2019
Replimune Reports Second Fiscal Quarter Financial Results and Provides Corporate Update
November 10, 2019
Replimune Presents Initial Clinical Data with RP1 that Strongly Supports Expansion of Clinical Programs in Melanoma and Cutaneous Squamous Cell Carcinoma (CSCC)
November 7, 2019
Replimune to Host Investor Event at the 34th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
October 30, 2019
Replimune Announces First Patient Enrolled in Phase 1 Clinical Trial of RP2 Alone and in Combination with Opdivo® in Advanced Cancer Patients
October 23, 2019
Replimune Provides Update on RP1 Clinical Development Program in Cutaneous Squamous Cell Carcinoma
October 14, 2019
Replimune Announces Presentation at the 2019 Society for Immunotherapy of Cancer (SITC) Annual Meeting
October 1, 2019
Replimune to Present at Chardan’s 3rd Annual Genetic Medicines Conference
September 30, 2019
Decks in 2019
- Corporate Update (November 2019)
Corporate update · 80 slides · Nov 8, 2019
- Investor Presentation (August 2019)
Investor deck · 23 slides · August 2019